Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Smith

Showing results (451-460 of 638) with videos related to

Pageof 64
Sort By:
Physical Review Letters|October 4, 2000
Molecular geometry fluctuation model for the mobility of conjugated polymersZ G Yu, D L Smith, A Saxena, et al.
Military Medicine|March 10, 2000
Concern over battlefield use of intravenous fluidsD H Jenkins, J D Josephs, D Mueller, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|March 15, 2003
Electromagnetic waves focused by a negative-index planar lensP F Loschialpo, D L Smith, D W Forester, et al.
European Journal of Pharmacology|March 5, 1991
The local monoaminergic dependency of spinal ketamineT Crisp, J M Perrotti, D L Smith, et al.
Lipids|January 1, 1989
Eskimo plasma constituents, dihomo-gamma-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid inhibit the release of atherogenic mitogensD L Smith, A L Willis, N Nguyen, et al.
Experientia|January 15, 1988
Goniothalamicin and annonacin: bioactive acetogenins from Goniothalamus giganteus (Annonaceae)A Alkofahi, J K Rupprecht, D L Smith, et al.
Journal of Natural Products|November 1, 1989
Majorenolide and majorynolide: a new pair of cytotoxic and pesticidal alkene-alkyne delta-lactones from Persea majorW W Ma, J E Anderson, C J Chang, et al.
The American Journal of Medicine|May 1, 1987
Vasodilators and regression of left ventricular hypertrophy. Hydralazine versus prazosin in hypertensive humansF H Leenen, D L Smith, R M Farkas, et al.
Journal of Natural Products|June 1, 1993
30-, 31-, and 32-hydroxybullatacinones: bioactive terminally hydroxylated annonaceous acetogenins from Annona bullataZ M Gu, X P Fang, L R Miesbauer, et al.
Journal of Psychoactive Drugs|July 30, 2020
Prescription Stimulant Use and Associated Risk Factors for Non-oral Use among 10 to 18 Year OldsYiyang Liu, Nathan D L Smith, Shawnta L Lloyd, et al.
Pageof 64

Showing results (451-460 of 638) with videos related to

Sort By:
Pageof 64
Physical Review Letters|October 4, 2000
Molecular geometry fluctuation model for the mobility of conjugated polymersZ G Yu, D L Smith, A Saxena, et al.
Military Medicine|March 10, 2000
Concern over battlefield use of intravenous fluidsD H Jenkins, J D Josephs, D Mueller, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|March 15, 2003
Electromagnetic waves focused by a negative-index planar lensP F Loschialpo, D L Smith, D W Forester, et al.
European Journal of Pharmacology|March 5, 1991
The local monoaminergic dependency of spinal ketamineT Crisp, J M Perrotti, D L Smith, et al.
Lipids|January 1, 1989
Eskimo plasma constituents, dihomo-gamma-linolenic acid, eicosapentaenoic acid and docosahexaenoic acid inhibit the release of atherogenic mitogensD L Smith, A L Willis, N Nguyen, et al.
Experientia|January 15, 1988
Goniothalamicin and annonacin: bioactive acetogenins from Goniothalamus giganteus (Annonaceae)A Alkofahi, J K Rupprecht, D L Smith, et al.
Journal of Natural Products|November 1, 1989
Majorenolide and majorynolide: a new pair of cytotoxic and pesticidal alkene-alkyne delta-lactones from Persea majorW W Ma, J E Anderson, C J Chang, et al.
The American Journal of Medicine|May 1, 1987
Vasodilators and regression of left ventricular hypertrophy. Hydralazine versus prazosin in hypertensive humansF H Leenen, D L Smith, R M Farkas, et al.
Journal of Natural Products|June 1, 1993
30-, 31-, and 32-hydroxybullatacinones: bioactive terminally hydroxylated annonaceous acetogenins from Annona bullataZ M Gu, X P Fang, L R Miesbauer, et al.
Journal of Psychoactive Drugs|July 30, 2020
Prescription Stimulant Use and Associated Risk Factors for Non-oral Use among 10 to 18 Year OldsYiyang Liu, Nathan D L Smith, Shawnta L Lloyd, et al.
Pageof 64